Diaxonhit SA Stock Euronext Paris
Equities
ALEHT
FR0013240934
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- EUR | - |
May. 08 | Eurobio Scientific: agreement with Myriad Genetics | CF |
May. 08 | Eurobio Scientific to Buy Gene Expression Test for Breast Cancer | MT |
Sales 2023 | 130M 141M | Sales 2024 * | 138M 150M | Capitalization | 153M 166M |
---|---|---|---|---|---|
Net income 2023 | 4M 4.34M | Net income 2024 * | 9M 9.77M | EV / Sales 2023 | 1.29 x |
Net Debt 2023 * | 23M 24.98M | Net cash position 2024 * | 9.9M 10.75M | EV / Sales 2024 * | 1.04 x |
P/E ratio 2023 |
38.3
x | P/E ratio 2024 * |
15.8
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 61.3% |
Managers | Title | Age | Since |
---|---|---|---|
Denis Fortier
CEO | Chief Executive Officer | - | 17-06-18 |
Director of Finance/CFO | 43 | 22-09-30 | |
Cathie Marsais
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Denis Fortier
CEO | Chief Executive Officer | - | 17-06-18 |
Director/Board Member | 68 | 09-11-03 | |
Director/Board Member | 67 | 17-06-14 |
1st Jan change | Capi. | |
---|---|---|
+67.53% | 63.85B | |
-0.77% | 41.83B | |
+44.08% | 40.65B | |
-10.72% | 27.12B | |
+13.30% | 26.52B | |
-22.79% | 18.69B | |
+4.70% | 12.73B | |
+24.10% | 12.11B | |
+27.41% | 12.07B |
- Stock Market
- Equities
- ALERS Stock
- ALEHT Stock